Lydie Nadal-Desbarats

Lydie Nadal-Desbarats

Auto-generated profile, based on publicly available information

Lydie Nadal-Desbarats

UMR 1253, iBrain, Université de Tours, Inserm, Tours, France

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2019 in Acta Physiologica
Verified
Journal Article
Closed access
PDF file
MKMalek Kammoun
Malek Kammoun
JPJérôme Piquereau
Jérôme Piquereau
LNLydie Nadal‐Desbarats
Lydie Nadal‐Desbarats
SMSandra Même
Sandra Même
MBMaud Beuvin
Maud Beuvin
SBSabine F. Bensamoun
Sabine F. Bensamoun

29 September 2021 in medRxiv
Verified
Preprint
Open access
PDF file
QFQuentin Faucher
Quentin Faucher
HAHugo Alarcan
Hugo Alarcan
FSFrançois-Ludovic Sauvage
François-Ludovic Sauvage
LFLionel Forestier
Lionel Forestier
EMElodie Miquelestorena-Standley
Elodie Miquelestorena-Standley
CBchantal barin
chantal barin
Background: Ischemia-related injury during the pre-implantation period impacts kidney graft outcome. Evaluating these lesions by a non-invasive approach before transplantation could help to understand the mechanisms of graft injury and identify potential biomarkers predictive of graft outcomes. This study aims to determine metabolomic content of graft perfusion fluids and its dependence on preservation time and to explore whether tubular transporters are possibly involved in the metabolomics variations observed. Methods: Kidneys were stored on hypothermic perfusion machines. We evaluated the metabolomic profiles of perfusion fluids (n=35) using Liquid Chromatography coupled with tandem Mass Spectrometry and studied the transcriptional expression of tubular transporters on pre-implantation biopsies (n=26). We used univariate and multivariate analyses to assess the impact of perfusion time on these parameters and their relationship with graft outcome. Results: Seventy-two metabolites were found in preservation fluids at the end of perfusion, of which 40% were already present in the native conservation solution. We observed an increase of 23 metabolites with longer perfusion time and a decrease for 8. The predictive model for time-dependent variation of metabolomics content showed good performance (R 2 = 76%, Q 2 = 54%, accuracy= 41%, permutations test significant). Perfusion time had no effect on the mRNA expression of transporters. We found no correlation between metabolomics and transporters expression. Neither the metabolomics profile nor the transporters expression were predictive of graft outcome. Conclusion: Our results open the way for further studies, focusing on both intra- and extra-tissue metabolome, to investigate whether transporter alterations can explain the variations observed in pre-implantation period.